133 related articles for article (PubMed ID: 12034030)
1. Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: relationship with radicality and outcome.
Galizia G; Lieto E; De Vita F; Romano C; Orditura M; Castellano P; Imperatore V; Infusino S; Catalano G; Pignatelli C
J Interferon Cytokine Res; 2002 Apr; 22(4):473-82. PubMed ID: 12034030
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery.
Galizia G; Orditura M; Romano C; Lieto E; Castellano P; Pelosio L; Imperatore V; Catalano G; Pignatelli C; De Vita F
Clin Immunol; 2002 Feb; 102(2):169-78. PubMed ID: 11846459
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic role of serum interleukin-18 in gastric cancer patients.
Thong-Ngam D; Tangkijvanich P; Lerknimitr R; Mahachai V; Theamboonlers A; Poovorawan Y
World J Gastroenterol; 2006 Jul; 12(28):4473-7. PubMed ID: 16874857
[TBL] [Abstract][Full Text] [Related]
4. Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies.
De Vita F; Orditura M; Galizia G; Romano C; Infusino S; Auriemma A; Lieto E; Catalano G
Cancer; 1999 Nov; 86(10):1936-43. PubMed ID: 10570416
[TBL] [Abstract][Full Text] [Related]
5. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of interleukin-10 and interleukin-6 in patients with lung cancer.
Wojciechowska-Lacka A; Matecka-Nowak M; Adamiak E; Lacki JK; Cerkaska-Gluszak B
Neoplasma; 1996; 43(3):155-8. PubMed ID: 8841501
[TBL] [Abstract][Full Text] [Related]
7. Phase-II randomized study of preoperative IL-2 administration in radically operable gastric cancer patients.
Romano F; Piacentini MG; Franciosi C; Caprotti R; De Fina S; Cesana G; Uggeri F; Conti M; Uggeri F
Hepatogastroenterology; 2004; 51(60):1872-6. PubMed ID: 15532847
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator.
De Vita F; Romano C; Orditura M; Galizia G; Martinelli E; Lieto E; Catalano G
J Interferon Cytokine Res; 2001 Jan; 21(1):45-52. PubMed ID: 11177580
[TBL] [Abstract][Full Text] [Related]
9. Serum interleukin-6 levels reflect disease status of gastric cancer.
Wu CW; Wang SR; Chao MF; Wu TC; Lui WY; P'eng FK; Chi CW
Am J Gastroenterol; 1996 Jul; 91(7):1417-22. PubMed ID: 8678006
[TBL] [Abstract][Full Text] [Related]
10. Circulating interleukin 6 concentrations and insulin resistance in patients with cancer.
Makino T; Noguchi Y; Yoshikawa T; Doi C; Nomura K
Br J Surg; 1998 Dec; 85(12):1658-62. PubMed ID: 9876070
[TBL] [Abstract][Full Text] [Related]
11. Low serum interleukin-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related hepatocellular carcinoma who underwent curative treatment.
Cho HJ; Kim SS; Ahn SJ; Park SY; Park JH; Kim JK; Wang HJ; Cheong JY; Cho SW
Cytokine; 2015 Jun; 73(2):245-52. PubMed ID: 25797190
[TBL] [Abstract][Full Text] [Related]
12. Serum interleukin-6 levels reflect the disease status of colorectal cancer.
Chung YC; Chang YF
J Surg Oncol; 2003 Aug; 83(4):222-6. PubMed ID: 12884234
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of circulating cytokines for stage III colon cancer.
Lee WS; Baek JH; You DH; Nam MJ
J Surg Res; 2013 Jun; 182(1):49-54. PubMed ID: 23010514
[TBL] [Abstract][Full Text] [Related]
14. Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer.
Szaflarska A; Szczepanik A; Siedlar M; Czupryna A; Sierzega M; Popiela T; Zembala M
Anticancer Res; 2009 Dec; 29(12):5005-12. PubMed ID: 20044609
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6--from the Groupe Francais d'Immunotherapie.
Negrier S; Perol D; Menetrier-Caux C; Escudier B; Pallardy M; Ravaud A; Douillard JY; Chevreau C; Lasset C; Blay JY;
J Clin Oncol; 2004 Jun; 22(12):2371-8. PubMed ID: 15197198
[TBL] [Abstract][Full Text] [Related]
16. Serum interleukin-6 level but not genotype predicts survival after resection in stages II and III gastric carcinoma.
Liao WC; Lin JT; Wu CY; Huang SP; Lin MT; Wu AS; Huang YJ; Wu MS
Clin Cancer Res; 2008 Jan; 14(2):428-34. PubMed ID: 18198221
[TBL] [Abstract][Full Text] [Related]
17. Serum interleukin-6 and -10 levels in patients with gastric cancer.
Ikeguchi M; Hatada T; Yamamoto M; Miyake T; Matsunaga T; Fukumoto Y; Yamada Y; Fukuda K; Saito H; Tatebe S
Gastric Cancer; 2009; 12(2):95-100. PubMed ID: 19562463
[TBL] [Abstract][Full Text] [Related]
18. SERUM CYTOKINE OF IL-2, IL-10 AND IL-12 LEVELS IN PATIENTS WITH STOMACH ADENOCARCINOMA.
Shokrzadeh M; Mohammadpour A; Hoseini V; Abediankenari S; Ghassemi-Barghi N; Tabari YS
Arq Gastroenterol; 2018; 55(4):385-389. PubMed ID: 30785523
[TBL] [Abstract][Full Text] [Related]
19. Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma.
De Vita F; Orditura M; Lieto E; Infusino S; Morgillo F; Martinelli E; Castellano P; Romano C; Ciardiello F; Catalano G; Pignatelli C; Galizia G
Cancer; 2004 Jan; 100(2):270-8. PubMed ID: 14716760
[TBL] [Abstract][Full Text] [Related]
20. Expression of interleukine-8 as an independent prognostic factor for sporadic colon cancer dissemination.
Nastase A; Paslaru L; Herlea V; Ionescu M; Tomescu D; Bacalbasa N; Dima S; Popescu I
J Med Life; 2014 Jun; 7(2):215-9. PubMed ID: 25408728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
